Skip to content

Geron GERN Total Current Liabilities

Total Current Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$19.16B-20.4%
Incyte logo
IncyteINCY
$1.49B-13.4%
Immunome logo
ImmunomeIMNM
$27.41M-11.0%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$86.17M-8.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$209M+8.9%
Celcuity logo
CelcuityCELC
$33.21M+0.9%

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$878.88M-8.6%
Enterprise value$964.15M-6.2%
P/S4.7×-172×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's total current liabilities?
Geron (GERN) reported total current liabilities of $73.57M in Q1 2026.
How has Geron's total current liabilities changed year-over-year?
Geron's total current liabilities increased by 16.7% year-over-year, from $63.03M to $73.57M.
What is the long-term trend for Geron's total current liabilities?
Over 5 years (2020 to 2025), Geron's total current liabilities has grown at a 29.2% compound annual growth rate (CAGR), from $30.94M to $111.54M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.